Sedation Depth in Neurocritical Care

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02317497

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Phase 2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Heidelberg University (from the registry)
Registry
  • NCT NCT02317497
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02317497. Randomized; no masking; primary purpose supportive care. Start 2016-09 (registry gives no type); primary completion 2018-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sedation Depth in Neurocritical Care
Acronym
MODERNISE
Condition
Sedation of Cerebrovascular Ventilated Critical Care Patients
Intervention (Other)
Intensive Care Sedation (depth, level)
Intervention (Drug)
Vasopressors to maintain normal blood pressure values, if needed
Intervention (Drug)
Osmotherapeutics to lowr intracranial pressure, if needed
Intervention (Procedure)
Endovascular stroke care to treat brain vessel occlusions, if needed
Intervention (Procedure)
Decompressive neurosurgery, if needed
Lead sponsor
Heidelberg University (class: other)

Record details

Record id
cardio:ct-nct02317497
Content hash
f691ff7085f5d59966d19cdce9a3d19fba20ea303c3edaa78708c619c220026f